-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Sarcoidosis is a systemic inflammatory disease characterized by noncaseating epithelioid granulomas of unknown etiology
Arrhythmia
Recently, a research article was published in Heart, an authoritative journal in the field of cardiology.
We conducted a prospective observational cohort study of patients with cardiac sarcoidosis diagnosed according to Japanese or Cardiac Rhythm Society guidelines between June 2008 and March 2020 at our hospital .
guideline diagnosis
The study included 89 consecutive patients with cardiac sarcoidosis
CONCLUSIONS: U-8-OHdG levels and concomitant VA are strong predictors of first-time sustained ventricular tachycardia/sudden cardiac death in patients with cardiac sarcoidosis, which facilitates stratification of cardiac events and provides relevant information on ventricular tachycardia
U-8-OHdG levels and concomitant VA are strong predictors of first-time sustained ventricular tachycardia/sudden cardiac death in patients with cardiac sarcoidosis, which facilitates stratification of cardiac events and provides insights into ventricular Information about tachycardia
Original source:
Ryosuke Yoshitomi.
Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac
sarcoidosis